The FDA is allowing suppliers of viral transport media — materials needed to transport samples of COVID-19 diagnostic tests — to be exempt from certain regulatory requirements in an effort to increase the availability of the materials.
The FDA released guidance July 20 saying commercial viral transport media manufacturers can ship the products without having to file a premarket notification or comply with unique device identification requirements.
The agency said it is hoping to increase access to viral transport media.The exemptions will only be in place for as long as COVID-19 is considered a public health emergency.
Under the guidance, manufacturers are required to tell their viral transport media customers that the products haven’t gone through the standard regulatory review process.
Find the full guidance here.
More articles on supply chain:
COVID-19 spreading too fast in US for LabCorp to meet demand, CEO says
AdvaMed creates national COVID-19 testing registry
FDA adds 20 more hand sanitizers to avoid due to methanol contamination
© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.